Friday, 31 December 2010

Danazol


Pronunciation: DAN-uh-zole
Generic Name: Danazol
Brand Name: Generic only. No brands available.

Do not use Danazol if you are pregnant. It is recommended that a pregnancy test be performed before starting Danazol. Effective, nonhormonal contraceptive (birth control) measures, such as diaphragms and condoms, should be used while taking Danazol. Danazol may cause serious harm to a fetus. If you become pregnant while taking Danazol, stop use and contact your health care provider. Life-threatening strokes and increased pressure in the head have occurred from using Danazol. Notify your doctor immediately if you develop any of the following: one-sided weakness, sudden vision changes, slurred speech, arm or leg pain, breathing trouble, chest pain, yellowing eyes/skin, dark urine, dizziness, fainting, swelling, stomach pain, head pain.





Danazol is used for:

Treating endometriosis, symptoms of fibrocystic breast disease, orgiant hives. It may also be used for other conditions as determined by your doctor.


Danazol is a synthetic steroid. It works by decreasing the level of certain hormones, which reduces the symptoms and severity of the diseases treated by Danazol.


Do NOT use Danazol if:


  • you are allergic to any ingredient in Danazol

  • you are pregnant or breast-feeding

  • you have undiagnosed vaginal bleeding

  • you have the blood disease porphyria or severely decreased liver, kidney, or heart function

Contact your doctor or health care provider right away if any of these apply to you.



Before using Danazol:


Some medical conditions may interact with Danazol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are planning to become pregnant

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of blood clots or stroke, cancer, heart failure, heart disease, or liver or kidney problems

Some MEDICINES MAY INTERACT with Danazol. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticoagulants (eg, warfarin), carbamazepine, cyclosporine, or macrolide immunosuppressants (eg, tacrolimus) because the actions and side effects of these medicines may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Danazol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Danazol:


Use Danazol as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Danazol may be taken with or without food.

  • If you are being treated for endometriosis or fibrocystic breast disease, you should begin treatment during menstruation.

  • Endometriosis patients - You must take Danazol consistently for 3 to 6 months. It may be necessary to take Danazol for 9 months.

  • If you miss a dose of Danazol, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Danazol.



Important safety information:


  • Danazol may cause dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Danazol. Using Danazol alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Do not take more medicine than prescribed unless advised to do so by your doctor.

  • It may take several months for Danazol to work. Do not stop using Danazol without checking with your doctor.

  • Use a barrier contraceptive (birth control), such as a condom or diaphragm, while taking Danazol.

  • Diabetes patients - Danazol may affect your blood sugar. Check blood sugar levels closely and ask your doctor before adjusting the dose of your diabetes medicine.

  • LAB TESTS, including liver function tests and complete blood cell counts, may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Danazol with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Do not use Danazol if you are pregnant. If you suspect that you could be pregnant, contact your doctor immediately. Danazol is excreted in breast milk. Do not breast-feed while taking Danazol.


Possible side effects of Danazol:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Acne; changes in menstrual flow; changes in semen volume and sperm count; emotional problems; excessively oily skin; flushing; hair loss; nervousness; reduction in breast size; sweating; vaginal itching or dryness; voice changes (hoarseness, sore throat, change in pitch); weight gain.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal hair growth; arm or leg pain; breathing trouble; chest pain; dark urine; dizziness; fainting; headache; nausea; one-sided weakness; slurred speech; sore throat or fever; stomach pain; swelling; unusual bleeding or bruising; vision problems; vomiting; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Danazol side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Danazol:

Store Danazol at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Danazol out of the reach of children and away from pets.


General information:


  • If you have any questions about Danazol, please talk with your doctor, pharmacist, or other health care provider.

  • Danazol is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Danazol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Danazol resources


  • Danazol Side Effects (in more detail)
  • Danazol Use in Pregnancy & Breastfeeding
  • Drug Images
  • Danazol Drug Interactions
  • Danazol Support Group
  • 3 Reviews for Danazol - Add your own review/rating


  • Danazol Prescribing Information (FDA)

  • Danazol Monograph (AHFS DI)

  • Danazol Professional Patient Advice (Wolters Kluwer)

  • danazol Concise Consumer Information (Cerner Multum)

  • danazol Advanced Consumer (Micromedex) - Includes Dosage Information

  • Danocrine Prescribing Information (FDA)



Compare Danazol with other medications


  • Angioedema
  • Endometriosis
  • Evan's Syndrome
  • Fibrocystic Breast Disease

Friday, 24 December 2010

Derinide




Derinide may be available in the countries listed below.


Ingredient matches for Derinide



Budesonide

Budesonide is reported as an ingredient of Derinide in the following countries:


  • Myanmar

International Drug Name Search

Thursday, 16 December 2010

Diclosyl




Diclosyl may be available in the countries listed below.


Ingredient matches for Diclosyl



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclosyl in the following countries:


  • Austria

International Drug Name Search

Monday, 13 December 2010

Micobar




Micobar may be available in the countries listed below.


Ingredient matches for Micobar



Barium Sulfate

Barium Sulfate is reported as an ingredient of Micobar in the following countries:


  • Ethiopia

International Drug Name Search

Cefonicid Alter




Cefonicid Alter may be available in the countries listed below.


Ingredient matches for Cefonicid Alter



Cefonicid

Cefonicid disodium salt (a derivative of Cefonicid) is reported as an ingredient of Cefonicid Alter in the following countries:


  • Spain

International Drug Name Search

Sunday, 12 December 2010

Sensorcaine


Sensorcaine is a brand name of bupivacaine, approved by the FDA in the following formulation(s):


SENSORCAINE (bupivacaine hydrochloride - injectable; injection)



  • Manufacturer: APP PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]

Has a generic version of Sensorcaine been approved?


Yes. The following products are equivalent to Sensorcaine:


bupivacaine hydrochloride injectable; injection



  • Manufacturer: HOSPIRA

    Approved Prior to Jan 1, 1982

    Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]


  • Manufacturer: HOSPIRA

    Approval date: February 17, 1986

    Strength(s): 0.5% [AP]


  • Manufacturer: HOSPIRA

    Approval date: February 17, 1987

    Strength(s): 0.25% [AP], 0.25% [AP]


  • Manufacturer: HOSPIRA

    Approval date: March 3, 1987

    Strength(s): 0.25% [AP], 0.5% [AP], 0.5% [AP], 0.75% [AP], 0.75% [AP]


  • Manufacturer: SAGENT STRIDES

    Approval date: October 18, 2011

    Strength(s): 0.25% [AP], 0.5% [AP]

BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE (bupivacaine hydrochloride injectable; injection)



  • Manufacturer: INTL MEDICATED

    Approval date: January 9, 2002

    Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]


  • Manufacturer: SAGENT STRIDES

    Approval date: October 18, 2011

    Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sensorcaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Sensorcaine.

See also...

  • Sensorcaine Solution Consumer Information (Wolters Kluwer)
  • Sensorcaine Consumer Information (Cerner Multum)
  • Bupivacaine Solution Consumer Information (Wolters Kluwer)
  • Bupivacaine in Dextrose Solution Consumer Information (Wolters Kluwer)
  • Bupivacaine Consumer Information (Cerner Multum)
  • Bupivacaine Hydrochloride AHFS DI Monographs (ASHP)

Trachisan




Trachisan may be available in the countries listed below.


Ingredient matches for Trachisan



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Trachisan in the following countries:


  • Georgia

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Trachisan in the following countries:


  • Poland

  • Slovenia

Lidocaine hydrochloride monohydrate (a derivative of Lidocaine) is reported as an ingredient of Trachisan in the following countries:


  • Croatia (Hrvatska)

  • Estonia

  • Germany

International Drug Name Search

Friday, 10 December 2010

Merigest




Merigest may be available in the countries listed below.


Ingredient matches for Merigest



Estradiol

Estradiol 17Ăź-valerate (a derivative of Estradiol) is reported as an ingredient of Merigest in the following countries:


  • Austria

  • Germany

  • Spain

  • Switzerland

Norethisterone

Norethisterone is reported as an ingredient of Merigest in the following countries:


  • Austria

  • Germany

  • Spain

  • Switzerland

International Drug Name Search

Wednesday, 8 December 2010

Furazolidon-T




Furazolidon-T may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Furazolidon-T



Furazolidone

Furazolidone is reported as an ingredient of Furazolidon-T in the following countries:


  • Germany

International Drug Name Search

Monday, 6 December 2010

Memotil




Memotil may be available in the countries listed below.


Ingredient matches for Memotil



Dihydroergocristine

Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Memotil in the following countries:


  • Greece

International Drug Name Search

Wednesday, 24 November 2010

Glibenclamida Calox




Glibenclamida Calox may be available in the countries listed below.


Ingredient matches for Glibenclamida Calox



Glibenclamide

Glibenclamide is reported as an ingredient of Glibenclamida Calox in the following countries:


  • Venezuela

International Drug Name Search

Monday, 22 November 2010

Gasteel




Gasteel may be available in the countries listed below.


Ingredient matches for Gasteel



Dimeticone

Dimeticone is reported as an ingredient of Gasteel in the following countries:


  • Japan

International Drug Name Search

Wednesday, 17 November 2010

Garacin




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Garacin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Garacin in the following countries:


  • United States

International Drug Name Search

Monday, 15 November 2010

Xalyn-Or




Xalyn-Or may be available in the countries listed below.


Ingredient matches for Xalyn-Or



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Xalyn-Or in the following countries:


  • Mexico

International Drug Name Search

Saturday, 13 November 2010

Glimewin




Glimewin may be available in the countries listed below.


Ingredient matches for Glimewin



Glimepiride

Glimepiride is reported as an ingredient of Glimewin in the following countries:


  • Hungary

International Drug Name Search

Friday, 12 November 2010

Gabapentine Qualimed




Gabapentine Qualimed may be available in the countries listed below.


Ingredient matches for Gabapentine Qualimed



Gabapentin

Gabapentin is reported as an ingredient of Gabapentine Qualimed in the following countries:


  • France

International Drug Name Search

Thursday, 11 November 2010

Oxcarbazépine




Oxcarbazépine may be available in the countries listed below.


Ingredient matches for Oxcarbazépine



Oxcarbazepine

Oxcarbazépine (DCF) is known as Oxcarbazepine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 10 November 2010

Systral Hydrocort




Systral Hydrocort may be available in the countries listed below.


Ingredient matches for Systral Hydrocort



Hydrocortisone

Hydrocortisone is reported as an ingredient of Systral Hydrocort in the following countries:


  • Germany

International Drug Name Search

Glisulin




Glisulin may be available in the countries listed below.


Ingredient matches for Glisulin



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Glisulin in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Monday, 8 November 2010

Piretanid Billix




Piretanid Billix may be available in the countries listed below.


Ingredient matches for Piretanid Billix



Piretanide

Piretanide is reported as an ingredient of Piretanid Billix in the following countries:


  • Germany

International Drug Name Search

Osteocal D3




Osteocal D3 may be available in the countries listed below.


Ingredient matches for Osteocal D3



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Osteocal D3 in the following countries:


  • France

  • Switzerland

Colecalciferol

Colecalciferol is reported as an ingredient of Osteocal D3 in the following countries:


  • France

  • Switzerland

International Drug Name Search

Sunday, 7 November 2010

Prazosan




Prazosan may be available in the countries listed below.


Ingredient matches for Prazosan



Pantoprazole

Pantoprazole is reported as an ingredient of Prazosan in the following countries:


  • India

International Drug Name Search

Saturday, 6 November 2010

Enoxa




Enoxa may be available in the countries listed below.


Ingredient matches for Enoxa



Enoxaparin

Enoxaparin is reported as an ingredient of Enoxa in the following countries:


  • Tunisia

International Drug Name Search

Friday, 5 November 2010

Gold Poisoning Medications


Topics under Gold Poisoning

  • Gold Poisoning, Mild (0 drugs)

  • Gold Poisoning, Severe (1 drug)





Drug List:

Wednesday, 3 November 2010

Retacnyl




Retacnyl may be available in the countries listed below.


Ingredient matches for Retacnyl



Tretinoin

Tretinoin is reported as an ingredient of Retacnyl in the following countries:


  • Argentina

  • Chile

  • Colombia

  • Costa Rica

  • Dominican Republic

  • El Salvador

  • France

  • Guatemala

  • Mexico

  • Panama

  • Peru

  • Singapore

  • South Africa

  • Thailand

  • Venezuela

International Drug Name Search

Wednesday, 27 October 2010

Glimepirida Kern Pharma




Glimepirida Kern Pharma may be available in the countries listed below.


Ingredient matches for Glimepirida Kern Pharma



Glimepiride

Glimepiride is reported as an ingredient of Glimepirida Kern Pharma in the following countries:


  • Spain

International Drug Name Search

Thursday, 21 October 2010

Gynezol 7




Gynezol 7 may be available in the countries listed below.


Ingredient matches for Gynezol 7



Miconazole

Miconazole is reported as an ingredient of Gynezol 7 in the following countries:


  • Georgia

  • Russian Federation

International Drug Name Search

Tuesday, 19 October 2010

Tracofung




Tracofung may be available in the countries listed below.


Ingredient matches for Tracofung



Fluconazole

Fluconazole is reported as an ingredient of Tracofung in the following countries:


  • Chile

International Drug Name Search

Sunday, 17 October 2010

Terramycin LA




Terramycin LA may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Terramycin LA



Oxytetracycline

Oxytetracycline dihydrate (a derivative of Oxytetracycline) is reported as an ingredient of Terramycin LA in the following countries:


  • Ireland

  • Netherlands

  • United Kingdom

International Drug Name Search

Saturday, 16 October 2010

Atacor




Atacor may be available in the countries listed below.


Ingredient matches for Atacor



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Atacor in the following countries:


  • Malta

International Drug Name Search

Tuesday, 12 October 2010

Alfakalcydol




Alfakalcydol may be available in the countries listed below.


Ingredient matches for Alfakalcydol



Alfacalcidol

Alfacalcidol is reported as an ingredient of Alfakalcydol in the following countries:


  • Poland

International Drug Name Search

Thursday, 7 October 2010

Alendroninezuur PCH




Alendroninezuur PCH may be available in the countries listed below.


Ingredient matches for Alendroninezuur PCH



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendroninezuur PCH in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 5 October 2010

Pravastatine Biogaran




Pravastatine Biogaran may be available in the countries listed below.


Ingredient matches for Pravastatine Biogaran



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatine Biogaran in the following countries:


  • France

International Drug Name Search

Monday, 27 September 2010

Allermist




Allermist may be available in the countries listed below.


Ingredient matches for Allermist



Fluticasone

Fluticasone furoate (a derivative of Fluticasone) is reported as an ingredient of Allermist in the following countries:


  • Japan

International Drug Name Search

Tuesday, 21 September 2010

Allergopos




Allergopos may be available in the countries listed below.


Ingredient matches for Allergopos



Antazoline

Antazoline phosphate (a derivative of Antazoline) is reported as an ingredient of Allergopos in the following countries:


  • Germany

Tetryzoline

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Allergopos in the following countries:


  • Germany

International Drug Name Search

Friday, 17 September 2010

Bisacodyl EG




Bisacodyl EG may be available in the countries listed below.


Ingredient matches for Bisacodyl EG



Bisacodyl

Bisacodyl is reported as an ingredient of Bisacodyl EG in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Sunday, 12 September 2010

Fluconazol Docpharma




Fluconazol Docpharma may be available in the countries listed below.


Ingredient matches for Fluconazol Docpharma



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Docpharma in the following countries:


  • Belgium

International Drug Name Search

Saturday, 11 September 2010

Mircera




In the US, MIRCERA (epoetin beta-methoxy polyethylene glycol systemic) is a member of the drug class recombinant human erythropoietins and is used to treat Anemia Associated with Chronic Renal Failure.

US matches:

  • Mircera

UK matches:

  • Mircera solution for injection in pre-filled syringe (SPC)

Ingredient matches for MIRCERA



Epoetin Beta-Methoxy Polyethylene Glycol

Methoxy polyethylene glycol-epoetin beta is reported as an ingredient of MIRCERA in the following countries:


  • Australia

  • Belgium

  • Croatia (Hrvatska)

  • Denmark

  • France

  • Germany

  • Greece

  • Hungary

  • Ireland

  • Netherlands

  • Norway

  • Slovakia

  • Sweden

  • Switzerland

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Megastene




Megastene may be available in the countries listed below.


Ingredient matches for Megastene



Sulbutiamine

Sulbutiamine is reported as an ingredient of Megastene in the following countries:


  • Argentina

International Drug Name Search

Thursday, 9 September 2010

Ramipril Actavis




Ramipril Actavis may be available in the countries listed below.


Ingredient matches for Ramipril Actavis



Ramipril

Ramipril is reported as an ingredient of Ramipril Actavis in the following countries:


  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Latvia

  • Lithuania

  • Netherlands

  • Slovakia

  • Sweden

  • Switzerland

International Drug Name Search

Capsidol




Capsidol may be available in the countries listed below.


Ingredient matches for Capsidol



Capsaicin

Capsaicin is reported as an ingredient of Capsidol in the following countries:


  • Mexico

  • Spain

International Drug Name Search

Wednesday, 1 September 2010

Cytil




Cytil may be available in the countries listed below.


Ingredient matches for Cytil



Misoprostol

Misoprostol is reported as an ingredient of Cytil in the following countries:


  • Colombia

International Drug Name Search

Friday, 27 August 2010

Formoterolo Viatris




Formoterolo Viatris may be available in the countries listed below.


Ingredient matches for Formoterolo Viatris



Formoterol

Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Formoterolo Viatris in the following countries:


  • Italy

International Drug Name Search

RiaSTAP


Generic Name: fibrinogen (fye BRIN oh gen)

Brand Names: RiaSTAP


What is fibrinogen?

Fibrinogen is a man-made form of a protein that occurs naturally in the body and helps the blood clot.


Fibrinogen is used to treat bleeding episodes in people who have a congenital fibrinogen deficiency.


Fibrinogen may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about fibrinogen?


You should not use this medication if you have ever had an allergic reaction to it, or if you have ever had any life-threatening allergic reaction.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using fibrinogen, tell your doctor if you have a history of stroke or blood clot.


Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine. This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not mix the medicine until you are ready to give the injection.


Stop your IV infusion and get emergency medical help if you have any of these signs of an allergic reaction: hives; wheezing or difficult breathing; feeling like you might pass out; or swelling of your face, lips, tongue, or throat.

Other serious side effects may include sudden numbness or weakness, chest pain, confusion, pain or swelling in your one or both legs, and problems with vision, speech, or balance.


Fibrinogen is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.


What should I discuss with my health care provider before using fibrinogen?


You should not use this medication if you have ever had an allergic reaction to it, or if you have ever had any other life-threatening allergic reaction.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using fibrinogen, tell your doctor if you have a history of stroke or blood clot.


FDA pregnancy category C. It is not known whether fibrinogen is harmful to an unborn baby. Before using this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether fibrinogen passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Fibrinogen is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.


How should I use fibrinogen?


Fibrinogen is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection. You may be shown how to use your medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine.


You will need to mix fibrinogen with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not mix fibrinogen with any other medicines, or give other medicines through the same IV line.


Fibrinogen contains no preservative. Once you have pierced the rubber top of a vial with a needle, you must use that vial right away or throw it away. Do not shake the medication vial (bottle). Vigorous shaking can ruin the medicine. Do not draw your fibrinogen dose into a syringe until you are ready to give yourself an injection. Do not use the medication if it has changed colors or has any particles in it. After mixing fibrinogen with a diluent, use it right away or store the mixture at room temperature and use it within 24 hours. The mixed medicine should be clear or slightly colored. Do not use the mixed medication if it has changed colors, is cloudy, or has any particles in it.

Each single-use vial (bottle) of this medicine is for one use only. Throw away the vial after one use, even if there is still some medicine left in it after injecting your dose.


To be sure this medication is helping your condition, your blood may need to be tested often. This will help your doctor determine how long to treat you with fibrinogen. Do not miss any follow-up visits to your doctor.


Use each disposable needle only one time. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.


Store the unmixed dry powder in a refrigerator or in a dark cool place. Keep the medicine protected from light and do not allow it to freeze. Throw away any unused vial after the expiration date on the label has passed.

What happens if I miss a dose?


Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of a fibrinogen overdose are not known.


What should I avoid while taking fibrinogen?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using fibrinogen.


Fibrinogen side effects


Stop your IV infusion and get emergency medical help if you have any of these signs of an allergic reaction: hives; wheezing or difficult breathing; feeling like you might pass out; or swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any other serious side effect, such as:

  • sudden numbness or weakness, especially on one side of the body;




  • sudden headache, confusion, problems with vision, speech, or balance;




  • sudden cough, rapid breathing, fast heart rate;




  • chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; or




  • pain or swelling in one or both legs.



Less serious side effects may include:



  • fever




  • chills;




  • nausea; or




  • vomiting.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect fibrinogen?


There may be other drugs that can interact with fibrinogen. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More RiaSTAP resources


  • RiaSTAP Side Effects (in more detail)
  • RiaSTAP Use in Pregnancy & Breastfeeding
  • RiaSTAP Support Group
  • 0 Reviews for RiaSTAP - Add your own review/rating


  • RiaSTAP Prescribing Information (FDA)

  • RiaSTAP Monograph (AHFS DI)

  • RiaSTAP MedFacts Consumer Leaflet (Wolters Kluwer)

  • RiaSTAP Consumer Overview



Compare RiaSTAP with other medications


  • Congenital Fibrinogen Deficiency


Where can I get more information?


  • Your pharmacist can provide more information about fibrinogen.

See also: RiaSTAP side effects (in more detail)


Thursday, 26 August 2010

Lisinopril comp. Heumann




Lisinopril comp. Heumann may be available in the countries listed below.


Ingredient matches for Lisinopril comp. Heumann



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril comp. Heumann in the following countries:


  • Germany

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril comp. Heumann in the following countries:


  • Germany

International Drug Name Search

Sunday, 22 August 2010

Fenuril




Fenuril may be available in the countries listed below.


Ingredient matches for Fenuril



Urea

Urea is reported as an ingredient of Fenuril in the following countries:


  • Finland

International Drug Name Search

Friday, 20 August 2010

Tamsuna




Tamsuna may be available in the countries listed below.


Ingredient matches for Tamsuna



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsuna in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 18 August 2010

Zeplan




Zeplan may be available in the countries listed below.


Ingredient matches for Zeplan



Simvastatin

Simvastatin is reported as an ingredient of Zeplan in the following countries:


  • Romania

International Drug Name Search

Friday, 13 August 2010

Elotaxin




Elotaxin may be available in the countries listed below.


Ingredient matches for Elotaxin



Oxaliplatin

Oxaliplatin is reported as an ingredient of Elotaxin in the following countries:


  • Latvia

International Drug Name Search

Thursday, 12 August 2010

Fenicol




Fenicol may be available in the countries listed below.


Ingredient matches for Fenicol



Chloramphenicol

Chloramphenicol is reported as an ingredient of Fenicol in the following countries:


  • Bahrain

  • Indonesia

  • Oman

International Drug Name Search

Gen-Fosinopril




Gen-Fosinopril may be available in the countries listed below.


Ingredient matches for Gen-Fosinopril



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Gen-Fosinopril in the following countries:


  • Canada

International Drug Name Search

Gliclazida Labesfal




Gliclazida Labesfal may be available in the countries listed below.


Ingredient matches for Gliclazida Labesfal



Gliclazide

Gliclazide is reported as an ingredient of Gliclazida Labesfal in the following countries:


  • Portugal

International Drug Name Search

Wednesday, 11 August 2010

Paroxetin Spirig




Paroxetin Spirig may be available in the countries listed below.


Ingredient matches for Paroxetin Spirig



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin Spirig in the following countries:


  • Switzerland

International Drug Name Search

Ramigamma HCT




Ramigamma HCT may be available in the countries listed below.


Ingredient matches for Ramigamma HCT



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramigamma HCT in the following countries:


  • Germany

Ramipril

Ramipril is reported as an ingredient of Ramigamma HCT in the following countries:


  • Germany

International Drug Name Search

Sunday, 8 August 2010

Lutamidal




Lutamidal may be available in the countries listed below.


Ingredient matches for Lutamidal



Bicalutamide

Bicalutamide is reported as an ingredient of Lutamidal in the following countries:


  • Brazil

  • Chile

  • Colombia

  • Peru

International Drug Name Search

Saturday, 7 August 2010

Vagimen




Vagimen may be available in the countries listed below.


Ingredient matches for Vagimen



Clotrimazole

Clotrimazole is reported as an ingredient of Vagimen in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Tuesday, 3 August 2010

Garmastan




Garmastan may be available in the countries listed below.


Ingredient matches for Garmastan



Guaiazulene

Guaiazulene is reported as an ingredient of Garmastan in the following countries:


  • Turkey

International Drug Name Search

Gaap




Gaap may be available in the countries listed below.


Ingredient matches for Gaap



Latanoprost

Latanoprost is reported as an ingredient of Gaap in the following countries:


  • Mexico

  • Peru

International Drug Name Search

Monday, 2 August 2010

Ruscogenin




CAS registry number (Chemical Abstracts Service)

0000472-11-7

Chemical Formula

C27-H42-O4

Molecular Weight

430

Therapeutic Category

Antihemorrhoidal agent

Chemical Name

Spirost-5-ene-1,3-diol, (1Ăź,3Ăź,25R)-

Foreign Name

  • Ruscogenin (German)

Brand Names

  • Flebodolor
    Spedrog-Caillon, Argentina


  • Ibuproct (Ruscogenin and Trimebutine)
    Olvos, Greece


  • Proctolog (Ruscogenin and Trimebutine)
    Juste, Spain; Pfizer, Singapore


  • Ruskorex (Ruscogenin and Tetracaine)
    GlaxoSmithKline, Poland

International Drug Name Search

Sunday, 25 July 2010

Lydenal




Lydenal may be available in the countries listed below.


Ingredient matches for Lydenal



Budesonide

Budesonide is reported as an ingredient of Lydenal in the following countries:


  • Greece

International Drug Name Search

Tuesday, 20 July 2010

Bisoprolol Labesfal




Bisoprolol Labesfal may be available in the countries listed below.


Ingredient matches for Bisoprolol Labesfal



Bisoprolol

Bisoprolol is reported as an ingredient of Bisoprolol Labesfal in the following countries:


  • Portugal

International Drug Name Search

Friday, 16 July 2010

Glucosamin Glomed




Glucosamin Glomed may be available in the countries listed below.


Ingredient matches for Glucosamin Glomed



Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glucosamin Glomed in the following countries:


  • Vietnam

International Drug Name Search

Docspirono




Docspirono may be available in the countries listed below.


Ingredient matches for Docspirono



Spironolactone

Spironolactone is reported as an ingredient of Docspirono in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Wednesday, 14 July 2010

NAF




NAF may be available in the countries listed below.


Ingredient matches for NAF



Nystatin

Nystatin is reported as an ingredient of NAF in the following countries:


  • Bangladesh

Sodium Fluoride

Sodium Fluoride is reported as an ingredient of NAF in the following countries:


  • Argentina

  • Bosnia & Herzegowina

International Drug Name Search

Monday, 12 July 2010

Tibonella




Tibonella may be available in the countries listed below.


Ingredient matches for Tibonella



Tibolone

Tibolone is reported as an ingredient of Tibonella in the following countries:


  • Colombia

International Drug Name Search

Sunday, 11 July 2010

Dirox




Dirox may be available in the countries listed below.


Ingredient matches for Dirox



Paracetamol

Paracetamol is reported as an ingredient of Dirox in the following countries:


  • Argentina

International Drug Name Search

Saturday, 10 July 2010

Hipotensil




Hipotensil may be available in the countries listed below.


Ingredient matches for Hipotensil



Captopril

Captopril is reported as an ingredient of Hipotensil in the following countries:


  • Portugal

International Drug Name Search

Respi-Tann Suspension


Pronunciation: car-beta-PEN-tane/soo-doe-e-FED-rin
Generic Name: Carbetapentane/Pseudoephedrine
Brand Name: Respi-Tann


Respi-Tann Suspension is used for:

Relieving symptoms of sinus congestion and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.


Respi-Tann Suspension is a decongestant and cough suppressant combination. The decongestant works by constricting blood vessels and reducing swelling in the nasal passages. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.


Do NOT use Respi-Tann Suspension if:


  • you are allergic to any ingredient in Respi-Tann Suspension

  • you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems

  • you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Respi-Tann Suspension:


Some medical conditions may interact with Respi-Tann Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of adrenal gland problems (eg, adrenal gland tumor), heart problems, high blood pressure, diabetes, blood vessel problems, stroke, glaucoma, an enlarged prostate or other prostate problems, seizures, or an overactive thyroid

  • if you have a history of asthma, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

Some MEDICINES MAY INTERACT with Respi-Tann Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline) because the side effects of Respi-Tann Suspension may be increased

  • Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased

  • Bromocriptine because the side effects may be increased by Respi-Tann Suspension

  • Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because the effectiveness may be decreased by Respi-Tann Suspension

This may not be a complete list of all interactions that may occur. Ask your health care provider if Respi-Tann Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Respi-Tann Suspension:


Use Respi-Tann Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Respi-Tann Suspension may be taken with or without food.

  • Shake well before using.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Respi-Tann Suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Respi-Tann Suspension.



Important safety information:


  • Respi-Tann Suspension may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Respi-Tann Suspension. Using Respi-Tann Suspension alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Do not take diet or appetite control medicines while you are taking Respi-Tann Suspension without checking with your doctor.

  • Respi-Tann Suspension contains pseudoephedrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains pseudoephedrine. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Do NOT exceed the recommended dose or take Respi-Tann Suspension for longer than prescribed without checking with your doctor.

  • If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.

  • Respi-Tann Suspension may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Respi-Tann Suspension. Use a sunscreen or protective clothing if you must be outside for a prolonged period.

  • Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Respi-Tann Suspension.

  • Use Respi-Tann Suspension with caution in the ELDERLY because they may be more sensitive to its effects.

  • Caution is advised when using Respi-Tann Suspension in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Respi-Tann Suspension, discuss with your doctor the benefits and risks of using Respi-Tann Suspension during pregnancy. It is unknown if Respi-Tann Suspension is excreted in breast milk. Do not breast-feed while taking Respi-Tann Suspension.


Possible side effects of Respi-Tann Suspension:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Respi-Tann side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Respi-Tann Suspension:

Store Respi-Tann Suspension at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Respi-Tann Suspension out of the reach of children and away from pets.


General information:


  • If you have any questions about Respi-Tann Suspension, please talk with your doctor, pharmacist, or other health care provider.

  • Respi-Tann Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Respi-Tann Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Respi-Tann resources


  • Respi-Tann Side Effects (in more detail)
  • Respi-Tann Use in Pregnancy & Breastfeeding
  • Respi-Tann Drug Interactions
  • Respi-Tann Support Group
  • 0 Reviews for Respi-Tann - Add your own review/rating


Compare Respi-Tann with other medications


  • Cough and Nasal Congestion

Friday, 9 July 2010

Levocof




Levocof may be available in the countries listed below.


Ingredient matches for Levocof



Levodropropizine

Levodropropizine is reported as an ingredient of Levocof in the following countries:


  • Costa Rica

  • El Salvador

  • Guatemala

  • Honduras

  • Mexico

  • Nicaragua

International Drug Name Search

Friday, 25 June 2010

Dimetapp Decongestant


Generic Name: pseudoephedrine (Oral route)

soo-doe-e-FED-rin

Commonly used brand name(s)

In the U.S.


  • 12 Hour Cold Maximum Strength

  • Biofed

  • Cenafed

  • Chlor-Trimeton Nasal Decongestant

  • Contac 12-Hour

  • Dimetapp Decongestant

  • Efidac 24 Pseudoephedrine

  • ElixSure Congestion Children's

  • Genaphed

  • Pediacare Decongestant Infants

  • Simply Stuffy

  • Sudafed

Available Dosage Forms:


  • Capsule, Extended Release

  • Tablet, Chewable

  • Tablet, Extended Release

  • Solution

  • Syrup

  • Liquid

  • Tablet

  • Capsule

  • Capsule, Liquid Filled

  • Suspension

Therapeutic Class: Decongestant


Pharmacologic Class: Alpha-Adrenergic Agonist


Uses For Dimetapp Decongestant


Pseudoephedrine is used to relieve nasal or sinus congestion caused by the common cold, sinusitis, and hay fever and other respiratory allergies. It is also used to relieve ear congestion caused by ear inflammation or infection.


Some of these preparations are available only with your doctor's prescription.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Before Using Dimetapp Decongestant


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Pseudoephedrine may be more likely to cause side effects in infants, especially newborn and premature infants, than in older children and adults.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of pseudoephedrine in the elderly with use in other age groups.


Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Clorgyline

  • Dihydroergotamine

  • Furazolidone

  • Iproniazid

  • Isocarboxazid

  • Linezolid

  • Moclobemide

  • Nialamide

  • Pargyline

  • Phenelzine

  • Procarbazine

  • Rasagiline

  • Selegiline

  • Toloxatone

  • Tranylcypromine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Guanethidine

  • Methyldopa

  • Midodrine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Type 2 diabetes mellitus—Use of pseudoephedrine may cause an increase in blood glucose levels

  • Enlarged prostate or

  • Glaucoma, or a predisposition to glaucoma or

  • Heart disease or blood vessel disease or

  • High blood pressure—Pseudoephedrine may make the condition worse

  • Overactive thyroid—Use of pseudoephedrine may make the condition worse

Proper Use of pseudoephedrine

This section provides information on the proper use of a number of products that contain pseudoephedrine. It may not be specific to Dimetapp Decongestant. Please read with care.


For patients taking pseudoephedrine extended-release capsules:


  • Swallow the capsule whole. However, if the capsule is too large to swallow, you may mix the contents of the capsule with jam or jelly and swallow without chewing.

  • Do not crush or chew before swallowing.

For patients taking pseudoephedrine extended-release tablets:


  • Swallow the tablet whole.

  • Do not break, crush, or chew before swallowing.

To help prevent trouble in sleeping, take the last dose of pseudoephedrine for each day a few hours before bedtime. If you have any questions about this, check with your doctor.


Take this medicine only as directed. Do not take more of it, do not take it more often, and do not take it for a longer period of time than recommended on the label (usually 7 days), unless otherwise directed by your doctor. To do so may increase the chance of side effects.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For nasal or sinus congestion:
    • For regular (short-acting) oral dosage form (capsules, oral solution, syrup, or tablets):
      • Adults and children 12 years of age and older—60 milligrams (mg) every four to six hours. Do not take more than 240 mg in twenty-four hours.

      • Children 6 to 12 years of age—30 mg every four to six hours. Do not take more than 120 mg in twenty-four hours.

      • Children 4 to 6 years of age—15 mg every four to six hours. Do not take more than 60 mg in twenty-four hours.

      • Children and infants up to 4 years of age—Use is not recommended .


    • For long-acting oral dosage form (extended-release capsules or extended-release tablets):
      • Adults and children 12 years of age and older—120 mg every 12 hours, or 240 mg every 24 hours. Do not take more than 240 mg in 24 hours.

      • Infants and children up to 12 years of age—Use is not recommended .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Dimetapp Decongestant


If symptoms do not improve within 7 days or if you also have a high fever, check with your doctor since these signs may mean that you have other medical problems.


Dimetapp Decongestant Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Rare - more common with high doses
  • Convulsions (seizures)

  • hallucinations (seeing, hearing, or feeling things that are not there)

  • irregular or slow heartbeat

  • shortness of breath or troubled breathing

Symptoms of overdose
  • Convulsions (seizures)

  • fast breathing

  • hallucinations (seeing, hearing, or feeling things that are not there)

  • increase in blood pressure

  • irregular heartbeat (continuing)

  • shortness of breath or troubled breathing (severe or continuing)

  • slow or fast heartbeat (severe or continuing)

  • unusual nervousness, restlessness, or excitement

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Nervousness

  • restlessness

  • trouble in sleeping

Less common
  • Difficult or painful urination

  • dizziness or light-headedness

  • fast or pounding heartbeat

  • headache

  • increased sweating

  • nausea or vomiting

  • trembling

  • unusual paleness

  • weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Dimetapp Decongestant side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Dimetapp Decongestant resources


  • Dimetapp Decongestant Side Effects (in more detail)
  • Dimetapp Decongestant Use in Pregnancy & Breastfeeding
  • Dimetapp Decongestant Drug Interactions
  • 1 Review for Dimetapp Decongestant - Add your own review/rating


  • Dimetapp Decongestant Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Pseudoephedrine Monograph (AHFS DI)

  • Pseudoephedrine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Drixoral Non-Drowsy Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Entex Liquid MedFacts Consumer Leaflet (Wolters Kluwer)

  • Entex Consumer Overview

  • Sudafed Consumer Overview

  • Tylenol Simply Stuffy Liquid MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dimetapp Decongestant with other medications


  • Nasal Congestion

Tuesday, 22 June 2010

Fluxinam




Fluxinam may be available in the countries listed below.


Ingredient matches for Fluxinam



Fluorometholone

Fluorometholone is reported as an ingredient of Fluxinam in the following countries:


  • Greece

International Drug Name Search

Thursday, 10 June 2010

Rublasone




Rublasone may be available in the countries listed below.


Ingredient matches for Rublasone



Bufexamac

Bufexamac is reported as an ingredient of Rublasone in the following countries:


  • Japan

International Drug Name Search

Tuesday, 8 June 2010

Gabexal




Gabexal may be available in the countries listed below.


Ingredient matches for Gabexal



Gabapentin

Gabapentin is reported as an ingredient of Gabexal in the following countries:


  • Indonesia

International Drug Name Search

Monday, 7 June 2010

GenRX Nifedipine




GenRX Nifedipine may be available in the countries listed below.


Ingredient matches for GenRX Nifedipine



Nifedipine

Nifedipine is reported as an ingredient of GenRX Nifedipine in the following countries:


  • Australia

International Drug Name Search

Ceftriaxone Biogaran




Ceftriaxone Biogaran may be available in the countries listed below.


Ingredient matches for Ceftriaxone Biogaran



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxone Biogaran in the following countries:


  • France

International Drug Name Search

Sunday, 6 June 2010

Pletasmin




Pletasmin may be available in the countries listed below.


Ingredient matches for Pletasmin



Tranexamic Acid

Tranexamic Acid is reported as an ingredient of Pletasmin in the following countries:


  • Japan

International Drug Name Search

Saturday, 15 May 2010

Reco




Reco may be available in the countries listed below.


Ingredient matches for Reco



Chloramphenicol

Chloramphenicol is reported as an ingredient of Reco in the following countries:


  • Indonesia

International Drug Name Search

Friday, 14 May 2010

Tracor




Tracor may be available in the countries listed below.


Ingredient matches for Tracor



Itraconazole

Itraconazole is reported as an ingredient of Tracor in the following countries:


  • Indonesia

International Drug Name Search

Frixitas




Frixitas may be available in the countries listed below.


Ingredient matches for Frixitas



Alprazolam

Alprazolam is reported as an ingredient of Frixitas in the following countries:


  • Indonesia

International Drug Name Search